PhoreMost
the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets
PhoreMost has raised €39M across 1 funding round from 8 investors, most recently a Series B round in Sep 2024. Based in London, UK; active in Healthtech. Data as of 28 Oct 2026.
London, UKwww.phoremost.com ↗
Total raised
€39M
€39,111,111
Funding rounds
1
Investors
8
distinct backers
Active since
2024-09
latest 2024-09
Funding by year
EUR raised per yearPhoreMost — funding by year — interactive chart.
Data table
| PhoreMost — funding by year | |
|---|---|
| 2024 | €39M |
Signals
High confidenceRaise-next likelihood48
base rate 48% for Series B
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-09-11 | Series B | €39M | Astellas Venture Management,BGF,Jonathan Milner,Morningside Ventures,o2h Ventures,Parkwalk Advisors+2 more | View deal → |